Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 18 analyst ratings
Hold
Strong Buy 17%
Buy 11%
Hold 72%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health Inc. is projected to achieve significant revenue growth in its Integrated Care segment, with guidance indicating a rise to $1.613 billion for the full year 2026, reflecting an annual increase of $34 million. The BetterHelp segment is also anticipated to experience a remarkable increase in insurance revenue, forecasted to grow from $13 million in 2025 to between $75 million and $90 million in 2026, thereby enhancing its revenue mix substantially. Additionally, the company's growth trajectory is supported by expanding international markets and a strong adjusted EBITDA forecast of $251.9 million for the Integrated Care segment, marking an increase of $12.6 million year-over-year and indicating strengthened profitability potential.

Bears say

Teladoc Health is facing significant financial challenges, particularly in its BetterHelp segment, which is anticipated to experience a decline in gross margin and a major adjusted EBITDA headwind by 2026 due to changes in revenue mix and membership reduction. The company's overall revenue growth has slowed, leading to lowered targets for BetterHelp that predict low-single-digit growth, indicating a stark contrast to previous performance trends and introducing uncertainty about future profitability. Furthermore, the transition of Integrated Care revenue from fee-based to visit-based models, compounded by expected declines in membership and operational expense cuts, may further dilute Teladoc's value proposition and hinder its growth trajectory.

Teladoc (TDOC) has been analyzed by 18 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 11% recommend Buy, 72% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Hold based on their latest research and market trends.

According to 18 analysts, Teladoc (TDOC) has a Hold consensus rating as of Apr 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.